Download PDF
Semin Reprod Med 2020; 38(02/03): 197-200
DOI: 10.1055/s-0040-1721503
Review Article

Eye to the Future in Adenomyosis Research

Lisa M. Halvorson
1   Gynecologic Health and Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland
,
Linda C. Giudice
2   Center for Reproductive Sciences, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, California
,
Elizabeth A. Stewart
3   Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Adenomyosis is a poorly understood and clinically underappreciated gynecologic disorder associated with substantial morbidity including dysmenorrhea, pelvic pain, heavy menstrual bleeding, infertility, and poor pregnancy outcomes. Substantial gaps persist in our understanding of essentially all aspects of this disorder – epidemiology, risk factors, pathogenesis, pathophysiology, diagnosis, and treatment. In this article, we summarize current thoughts on future directions in basic, translational, and clinical adenomyosis research.

Keywords

Adenomyosis - research


Publication History

Article published online:
11 December 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Taylor HS, Giudice LC, Lessey BA. et al. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. N Engl J Med 2017; 377 (01) 28-40
    CrossrefPubMedGoogle Scholar
  • 2 Rogers PA, Adamson GD, Al-Jefout M. et al; WES/WERF Consortium for Research Priorities in Endometriosis. Research Priorities for Endometriosis. Reprod Sci 2017; 24 (02) 202-226
    Google Scholar
  • 3 Stewart EA, Lytle BL, Thomas L, Wegienka GR, Jacoby V, Diamond MP. et al. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design. Am J Obstet Gynecol 2018; 219 (01) 95e1-95e10
    CrossrefPubMedGoogle Scholar
  • 4 Vannuccini S, Petraglia F. Recent advances in understanding and managing adenomyosis. F1000 Res 2019; 8: 8
    Google Scholar
  • 5 Zhai J, Vannuccini S, Petraglia F, Giudice L. Adenomyosis: mechanisms and pathogenesis. Semin Reprod Med 2020; 38: 129-143
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Yeh CC, Su FH, Tzeng CR, Muo CH, Wang WC. Women with adenomyosis are at higher risks of endometrial and thyroid cancers: A population-based historical cohort study. PLoS One 2018; 13 (03) e0194011
    CrossrefPubMedGoogle Scholar
  • 7 Guo S, Li Z, Yan L, Sun Y, Feng Y. GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity. Drug Des Devel Ther 2018; 12: 1621-1631
    CrossrefPubMedGoogle Scholar
  • 8 Razavi M, Maleki-Hajiagha A, Sepidarkish M, Rouholamin S, Almasi-Hashiani A, Rezaeinejad M. Systematic review and meta-analysis of adverse pregnancy outcomes after uterine adenomyosis. Int J Gynaecol Obstet 2019; 145 (02) 149-157
    CrossrefPubMedGoogle Scholar
  • 9 Habiba M, Pluchino N, Petignat P, Bianchi P, Brosens IA, Benagiano G. Adenomyosis and Endometrial Cancer: Literature Review. Gynecol Obstet Invest 2018; 83 (04) 313-328
    CrossrefPubMedGoogle Scholar
  • 10 Champaneria R, Abedin P, Daniels J, Balogun M, Khan KS. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol Scand 2010; 89 (11) 1374-1384
    CrossrefPubMedGoogle Scholar
  • 11 Loring M, Chen T, Isaacson K. Symptoms of adenomyosis and overlapping diseases. Semin Reprod Med 2020; 38: 144-152
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 O'Shea A, Figueiredo G, Lee S. Imaging diagnosis of adenomyosis. Semin Reprod Med 2020; 38: 119-128
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Acar S, Millar E, Mitkova M, Mitkov V. Value of ultrasound shear wave elastography in the diagnosis of adenomyosis. Ultrasound 2016; 24 (04) 205-213
    CrossrefPubMedGoogle Scholar
  • 14 Antero MF, Ayhan A, Segars J, Shih I. Pathology and pathogenesis of adenomyosis. Semin Reprod Med 2020; 38: 108-118
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Herndon CN, Aghajanova L, Balayan S. et al. Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis. Reprod Sci 2016; 23 (10) 1289-1303
    CrossrefPubMedGoogle Scholar
  • 16 Munro MG. Classification and Reporting Systems for Adenomyosis. J Minim Invasive Gynecol 2020; 27 (02) 296-308
    CrossrefPubMedGoogle Scholar
  • 17 Tsang JYS, Tse GM. Molecular Classification of Breast Cancer. Adv Anat Pathol 2020; 27 (01) 27-35
    CrossrefPubMedGoogle Scholar
  • 18 Marquardt R, Jeong JW, Asgerally T, Fazleabas A. Animal models of adenomyosis. Semin Reprod Med 2020; 38: 170-180
    PubMedGoogle Scholar
  • 19 Gnecco J, Brown A, Kan E. et al. Physiomimetic models of adenomyosis. Semin Reprod Med 2020; 38: 181-198
    PubMedGoogle Scholar
  • 20 Cope AG, Ainsworth AJ, MD Stewart EA. Current and future medical therapies for adenomyosis. Semin Reprod Med 2020; 38: 153-158
    PubMedGoogle Scholar
  • 21 Chen J, Porter AE, Kho K. Current and future surgical and interventional management options for adenomyosis. Semin Reprod Med 2020; 38: 159-169
    PubMedGoogle Scholar